期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
血小板源性生长因子对体外培养子宫肌瘤细胞增殖的影响 被引量:6
1
作者 汪宏波 梁铭霖 王泽华 《中国妇幼保健》 CAS 北大核心 2005年第5期539-542,共4页
 目的: 研究血小板源性生长因子 (Platete-DerivedGrowthFactor, PDGF) 对体外培养的子宫肌瘤细胞和子宫平滑肌细胞增殖性核抗原 (PCNA) 和细胞内前胶原α1多肽的表达的影响。方法: 用基因重组人PDGF-AB (10ng/ml) 作用体外培养的子宫...  目的: 研究血小板源性生长因子 (Platete-DerivedGrowthFactor, PDGF) 对体外培养的子宫肌瘤细胞和子宫平滑肌细胞增殖性核抗原 (PCNA) 和细胞内前胶原α1多肽的表达的影响。方法: 用基因重组人PDGF-AB (10ng/ml) 作用体外培养的子宫肌瘤细胞, 以邻近正常子宫肌层细胞作对照, 用RT-PCR法从mRNA水平检测在有无PDGF-AB作用下, PCNA、前胶原α1多肽 (Ⅰ、Ⅲ) 表达的差异; 用免疫组化SABC法从蛋白水平显示PDGF对PCNA表达的影响。结果: 两种细胞受PDGF-AB刺激后, PCNA、collagenα1 (Ⅰ) 表达均有增加, 但两者在肌瘤细胞中表达的增加显著高于子宫平滑肌细胞 (P<0. 01); 而collagenα1 (Ⅲ) 在子宫肌瘤细胞和子宫平滑肌细胞中的变化无显著性差异。结论: PDGF在体外可同时促进子宫肌瘤细胞增殖和细胞外基质分泌的增加, 从而使肌瘤组织不断增长。 展开更多
关键词 子宫肌瘤血小板源性生长因子(PDGF—AB) 细胞增殖性核抗原(PCNA) 前胶原α1多肽(Ⅰ、Ⅲ)
下载PDF
VEGF在子宫肌瘤发生发展中的表达及其意义 被引量:18
2
作者 陈芳芬 杨泽妹 +1 位作者 许爱玲 吴海莉 《实用癌症杂志》 2018年第5期704-706,710,共4页
目的探讨血管内皮生长因子(VEGF)在子宫肌瘤发生发展中的表达及其意义。方法选取60例子宫肌瘤患者的临床资料进行研究。利用超声监测患者子宫肌瘤数量和径线值。手术过程中取小块子宫肌瘤和正常肌层组织,并利用免疫印迹法测定患者VEGF... 目的探讨血管内皮生长因子(VEGF)在子宫肌瘤发生发展中的表达及其意义。方法选取60例子宫肌瘤患者的临床资料进行研究。利用超声监测患者子宫肌瘤数量和径线值。手术过程中取小块子宫肌瘤和正常肌层组织,并利用免疫印迹法测定患者VEGF蛋白含量。结果子宫肌瘤组织VEGF及其受体(VEGFR1、VEGFR2)蛋白表达水平均明显高于正常肌层组织,差异有统计学意义(P<0.05);正常组织与分泌期、增生期子宫肌瘤组织中的VEGF及其受体蛋白表达水平之间比较,差异有统计学意义(P<0.05);但是各自月经周期差异无统计学意义(P>0.05)。VEGFR2表达水平明显高于VEGFR1,VEGF与VEGFR2表达水平与子宫瘤数量呈正相关。结论 VEGF在子宫肌瘤发生和发展中有重要的作用,研制出VEGF及其受体蛋白拮抗剂能够有效地抑制子宫肌瘤的生长。 展开更多
关键词 VEGF 子宫肌瘤 发生 肌瘤生长 作用
下载PDF
阴道彩色超声在诊断子宫肌瘤中的意义及超声表现分析 被引量:1
3
作者 方菲菲 《影像研究与医学应用》 2022年第2期113-115,共3页
目的:研究阴道彩色超声在诊断子宫肌瘤中的意义及超声表现。方法:选取2021年7月—9月在常州市武进第四人民医院治疗的子宫肌瘤患者60例为研究对象,所有患者均进行阴道彩色超声诊断,总结分析患者超声表现,同时对患者舒张期血流、收缩期... 目的:研究阴道彩色超声在诊断子宫肌瘤中的意义及超声表现。方法:选取2021年7月—9月在常州市武进第四人民医院治疗的子宫肌瘤患者60例为研究对象,所有患者均进行阴道彩色超声诊断,总结分析患者超声表现,同时对患者舒张期血流、收缩期血流、分流血流阻力指数进行观察与记录。结果:60例患者经阴道彩色超声检查显示低回声39例(65.00%),等回声12例(20.00%),混合回声9例(15.00%);肌壁间肌瘤37例(61.67%),浆膜下肌瘤15例(25.00%),黏膜下肌瘤8例(13.33%)。患者舒张期血流为(5.82±0.13)cm/s,收缩期血流为(44.68±1.35)cm/s,分流血流阻力指数为(0.78±0.11)。结论:子宫肌瘤诊断中应用阴道彩色超声的临床价值非常高,可通过超声表现与血流动力学指标对疾病予以鉴别诊断,进而为临床治疗提供参考依据,值得临床推荐与应用。 展开更多
关键词 子宫肌瘤 阴道彩色超声诊断 回声类型 肌瘤生长部位
下载PDF
Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors,leiomyomas and schwannomas 被引量:9
4
作者 Toshiyuki Nakayama Yang Cheul Cho +4 位作者 Yuka Mine Ayumi Yoshizaki Shinji Naito Chun Yang Wen Ichiro Sekine 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第38期6182-6187,共6页
AIM: To investigate the role of vascular endothelial growth factor (VEGF/and its receptors VEGFR-1 and 2 in the growth and differentiation of gastrointestinal strornal tumors (GISTs). METHODS: Thirty-three GISTs,... AIM: To investigate the role of vascular endothelial growth factor (VEGF/and its receptors VEGFR-1 and 2 in the growth and differentiation of gastrointestinal strornal tumors (GISTs). METHODS: Thirty-three GISTs, 15 leiomyomas and 6 schwannomas were examined by immunohistochemistry in this study. RESULTS: VEGF protein was expressed in the cytoplasm of tumor cells, and VEGFRol and 2 were expressed both in the cytoplasm and on the membrane of all tumors. Irnrnunohistochernical staining revealed that 26 GISTs (78.8%), 9 leiornyornas (60.0%) and 3 schwannornas (50.0%/were positive for VEGF; 24 GISTs (72.7%/, 12 leiornyornas (80.0%) and 4 schwannornas (66.7%) were positive for VEGFR-1; 30 GISTs (90.9%/, 5 leiornyornas (33.3%/and 4 schwannornas (66.7%) were positive for VEGFR-2. VEGFR-2 expression was statistically different between GISTs and leiomyomas (P 〈 0.0001). However, there was no correlation between the expression of VEGF pathway componenets and the clinical risk categories. CONCLUSION: Our results suggest that the VEGF pathway may play an important role in the differentiation of GISTs, leiomyomas and schwannomas. 展开更多
关键词 Gastrointestinal stromal tumor LEIOMYOMA SCHWANNOMA Vascular endothelial growth factor Vascular endothelial growth factor receptors
下载PDF
GASTROINTESTINAL STROMAL TUMORS:IMAGING FINDINGS
5
作者 Radfan Mahyoub 刘玉 陈克敏 《Medical Bulletin of Shanghai Jiaotong University》 CAS 2010年第2期77-83,共7页
Gastrointestinal stromal tumor(GIST)is a non-epithelial neoplasm arising from the wall of the gastrointestinal(GI)tract.It is most frequently found in the stomach(60%-70%),followed by the small intestine(20%-30%),the ... Gastrointestinal stromal tumor(GIST)is a non-epithelial neoplasm arising from the wall of the gastrointestinal(GI)tract.It is most frequently found in the stomach(60%-70%),followed by the small intestine(20%-30%),the colorectum(10%),and the esophagus(<5%).Some GISTs occur in the omentum,mesentery and retroperitoneum.GIST arising in the retroperitoneum is extremely rare,and its radiological findings have not been well described.However GISTs account for 2%-3% of all gastric tumors.GISTs are one of the most common mesenchymal tumors of the gastrointestinal tract.GIST referred to in the older medical literature as leiomyomas,leiomyoblastomas,and leiomyosarcomas because they were believed to originate from the smooth muscle layers of the wall of the gastrointestinal tract.Recently,however,immunoreactivity for KIT(CD117,a tyrosine kinase growth factor receptor)has differentiated gastrointestinal stromal tumors from true leiomyomas,leiomyosarcomas,neurofibromas,and schwannomas.In this review,we summarize the imaging findings of gastrointestinal stromal tumors and to determine whether some imaging features are useful for predicting malignancy in these tumors. 展开更多
关键词 gastric tumor intestinal tumor CT MRI X-ray
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部